Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8902635rdf:typepubmed:Citationlld:pubmed
pubmed-article:8902635lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C1333302lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C1705130lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C1333202lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C0376315lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C1148643lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C0205173lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:8902635lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:8902635pubmed:issue3lld:pubmed
pubmed-article:8902635pubmed:dateCreated1997-2-27lld:pubmed
pubmed-article:8902635pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:abstractTextRabphilin 3A and Doc2 alpha are synaptic vesicle-associated proteins, and are thought to function as Ca2+ sensors in neurotransmitter release. If either rabphilin 3A or Doc2 alpha plays a role in membrane trafficking, like the synaptotagmins, then non-neural forms should be present. Here we describe the isolation of a mouse cDNA which encodes a novel Doc2 homologue (Doc2 beta) that is present in all tissues. The encoded protein, which is highly homologous to human Doc2 alpha (70% identity), is composed of 412 amino acids with a calculated relative molecular mass (M(r)) of 45,837. The sequence identity is especially high in two C2 domains (74% in C2A and 84% in C2B). Northern and Western blot analyses have shown that Doc2 beta is expressed in all cell lines and tissues tested. Ca(2+)-dependent phospholipid binding assaying of recombinant fusion proteins revealed that the single C2A domain, but not the C2B domain, of Doc2 beta binds phosphatidycholine and phosphatidylserine (2.5:1, w/w) liposomes. The binding is Ca(2+)-dependent, with an EC50 value of approximately 1 microM and a Hill coefficient of approximately 3, which are comparable to those of synaptotagmins, rabphilin 3A and Doc2 alpha. Our results suggest that Doc2 beta is involved in constitutive membrane trafficking.lld:pubmed
pubmed-article:8902635pubmed:languageenglld:pubmed
pubmed-article:8902635pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:citationSubsetIMlld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8902635pubmed:statusMEDLINElld:pubmed
pubmed-article:8902635pubmed:monthSeplld:pubmed
pubmed-article:8902635pubmed:issn0021-924Xlld:pubmed
pubmed-article:8902635pubmed:authorpubmed-author:MikoshibaKKlld:pubmed
pubmed-article:8902635pubmed:authorpubmed-author:KojimaTTlld:pubmed
pubmed-article:8902635pubmed:authorpubmed-author:FukudaMMlld:pubmed
pubmed-article:8902635pubmed:authorpubmed-author:ArugaJJlld:pubmed
pubmed-article:8902635pubmed:issnTypePrintlld:pubmed
pubmed-article:8902635pubmed:volume120lld:pubmed
pubmed-article:8902635pubmed:ownerNLMlld:pubmed
pubmed-article:8902635pubmed:authorsCompleteYlld:pubmed
pubmed-article:8902635pubmed:pagination671-6lld:pubmed
pubmed-article:8902635pubmed:dateRevised2007-12-19lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:meshHeadingpubmed-meshheading:8902635-...lld:pubmed
pubmed-article:8902635pubmed:year1996lld:pubmed
pubmed-article:8902635pubmed:articleTitleCalcium-dependent phospholipid binding to the C2A domain of a ubiquitous form of double C2 protein (Doc2 beta).lld:pubmed
pubmed-article:8902635pubmed:affiliationMolecular Neurobiology Laboratory, Tsukuba Life Science Center, Institute of Physical and Chemical Research (RIKEN), Ibaraki.lld:pubmed
pubmed-article:8902635pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8902635pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8902635pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:8447entrezgene:pubmedpubmed-article:8902635lld:entrezgene
entrez-gene:13447entrezgene:pubmedpubmed-article:8902635lld:entrezgene
entrez-gene:81820entrezgene:pubmedpubmed-article:8902635lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8902635lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8902635lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8902635lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8902635lld:pubmed